arrow
Back
K

Kim Linton

University of Manchester

34H-index
347Paper Count
5.5KCitation Count
Published Papers 60
Publication Date
MRD-negativity by PBMCs and ctDNA confirms deep and durable responses following epcoritamab monotherapy in R/R FL
err2026-07-14
err0
errOAAI
errIşıl Altıntaş; Christopher Morehouse; Elena Favaro; Ali Rana; John Karavitis; Edith Szafer-Glusman; Kevin Zhao; Kim Linton; Alexey Danilov; Ann S. LaCasce; Lorenzo Falchi; Jessica Okosun; Tahamtan Ahmadi; Mark Fereshteh; Maria Jure-Kunkel; David Soong; Andrew J. Steele
errShare
errSave
Epcoritamab, lenalidomide, and rituximab versus lenalidomide and rituximab for relapsed or refractory follicular lymphoma (EPCORE FL-1): a global, open-label, randomised, phase 3 trial
err2025-12-07
err0
errOAAI
errLorenzo Falchi; Marcel Nijland; Huiqiang Huang; Kim M Linton; John F Seymour; Rong Tao; Michal Kwiatek; Abel Costa; Theodoros P Vassilakopoulos; Richard Greil; Ana Jiménez-Ubieto; Shane A Gangatharan; Ohad Benjamini; Catherine Thieblemont; Alessandra Tucci; Anna Elinder-Camburn; Arpad Illes; Jan Novak; Miguel A Pavlovsky; Andrew McDonald
errShare
errSave
Fixed-Duration Epcoritamab Plus R2 Drives Favorable Outcomes in Relapsed or Refractory Follicular Lymphoma
errBlood
IF23.1
err2025-09-10
err0
errOAAI
errLorenzo Falchi; Anna Sureda; Sirpa Leppä; Joost S.P. Vermaat; Marcel Nijland; Jacob Haaber Christensen; Sven de Vos; Harald Holte; Reid W. Merryman; Pieternella J. Lugtenburg; Pau Abrisqueta; Kim M. Linton; Gauri Sunkersett; Daniela Hoehn; Ali Rana; Aqeel Abbas; Jennifer Marek; Yi Hao; Andrew J. Steele; Christopher Morehouse; Martin Hutchings; David Belada
errShare
errSave
Indirect comparison of epcoritamab vs chemoimmunotherapy, mosunetuzumab, or odronextamab in follicular lymphoma
err2025-06-09
err0
errOAAI
errAlexey V. Danilov; Swetha Kambhampati Thiruvengadam; Kim Linton; Karen Cumings; Viktor Chirikov; Alex Mutebi; Savreet Bains Chawla; Anindit Chhibber; Fernando Rivas Navarro; Felipe Marques Gonçalves; Anthony Wang; Zhijie Ding; Abualbishr Alshreef; Elena Favaro; Daniela Hoehn; Anna Sureda
errShare
errSave
The REFRACT trial: implementation of Bayesian power priors in a randomised, sequential phase II adaptive platform trial
err2025-05-03
err0
errOAAI
errGaskell, Charlotte; Linton, Kim; Bishton, Mark; McIlroy, Graham; Lax, Sian; Fox, Sonia; Hopkins, Louise; Collings, Rebecca; Rhodes, Malcolm; Seale, Tania; Jackson, Aimee
errShare
errSave
Glofitamab and Epcoritamab in the Real World: A UK Multicentre Retrospective Analysis of Efficacy, Tolerability and Practical Implications
errBLOOD
IF23.1
err2024-11-05
err1
PREAI
errHaynes, Euan; Ediriwickrema, Kushani; Lawless, Sarah; Joyce, Kevin; Wells, Matthew; Smith, Jeffrey; Linton, Kim; Santarsieri, Anna; Follows, George; Willan, John; Osborn, Robert; Wilson, Matthew; Mckay, Pamela; Baloch, Mahina; Mcculloch, Rory; Gleeson, Mary; Wrench, David; Foldes, David; Kanfer, Edward; Maw, Kyaw Zin; Kuhnl, Andrea; Ahearne, Matthew; Owen, Mary; Norman, Jane; De Silva, Ravindu; Shah, Nimish; Ambrose, Harriet; Fox, Christopher P.; Qasim, Janine; Collins, Graham P.; Vickers, Martha; Tucker, David; Chan, Li Yuan; Lyengar, Sunil; el-Sharkawi, Dima; Auer, Rebecca; Cox, Catherine; Hiew, Hwai Jing; Davies, Andrew J.; Kelsey, Philippa; Lewis, David John; Martin, Abigail; Preston, Gavin; Culligan, Dominic J.; Broom, Angus; Wilson, William; Osborne, Wendy; Townsend, William
errShare
errSave
CTPS1 is a novel therapeutic target in cutaneous T cell lymphoma
err2024-10-01
err0
PREAI
errBeer, P.; Ahearne, M.; Collins, G.; El-Sharkawi, D.; Fox, C.; Lewis, D.; Linton, K.; Patel, M.; Tees, M.; Schwartz, B.; Higgins, M.; Noel, R.; Michot, J. -M.; Ribrag, V.
errShare
errSave
Epcoritamab in relapsed/refractory large B-cell lymphoma: 2-year follow-up from the pivotal EPCORE NHL-1 trial
errLEUKEMIA
IF13.4
err2024-09-25
err0
errOAAI
errThieblemont, Catherine; Karimi, Yasmin H.; Ghesquieres, Herve; Cheah, Chan Y.; Clausen, Michael Roost; Cunningham, David; Jurczak, Wojciech; Do, Young Rok; Gasiorowski, Robin; Lewis, David John; Kim, Tae Min; van der Poel, Marjolein; Poon, Michelle Limei; Feldman, Tatyana; Linton, Kim M.; Sureda, Anna; Hutchings, Martin; Dinh, Minh H.; Kilavuz, Nurgul; Soong, David; Mark, Thomas; Sacchi, Mariana; Phillips, Tycel; Lugtenburg, Pieternella J.
errShare
errSave
The PI3Kδ inhibitor zandelisib on intermittent dosing in relapsed/refractory follicular lymphoma: Results from a global phase 2 study
err2024-08-06
err0
errOAAI
errZelenetz, Andrew D.; Jurczak, Wojciech; Ribrag, Vincent; Linton, Kim; Collins, Graham P.; Jimenez, Javier L.; Bishton, Mark; Dholaria, Bhagirathbhai; Mengarelli, Andrea; Phillips, Tycel J.; Sungala, Nagendraprasad; Musuraca, Gerardo; Sheehy, Oonagh; Van Den Neste, Eric; Odera, Mitsuhiko; Miao, Lu; Gold, Daniel P.; Ghalie, Richard G.; Zinzani, Pier L.
errShare
errSave
Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study
err2024-08-01
err8
PREAI
errLinton, Kim M.; Vitolo, Umberto; Jurczak, Wojciech; Lugtenburg, Pieternella J.; Gyan, Emmanuel; Sureda, Anna; Christensen, Jacob Haaber; Hess, Brian; Tilly, Herve; Cordoba, Raul; Lewis, David John; Okada, Craig; Hutchings, Martin; Clausen, Michael Roost; Sancho, Juan-Manuel; Cochrane, Tara; Leppa, Sirpa; Chamuleau, Martine E. D.; Gernhardt, Diana; Altintas, Isil; Liu, Yan; Ahmadi, Tahamtan; Dinh, Minh H.; Hoehn, Daniela; Favaro, Elena; Elliott, Brian; Thieblemont, Catherine; Vose, Julie M.
errShare
errSave
Investigator choice of standard therapy versus sequential novel therapy arms in the treatment of relapsed follicular lymphoma (REFRACT): study protocol for a multi-centre, open-label, randomised, phase II platform trial
err2024-03-25
err0
errOAAI
errMcilroy, Graham; Lax, Sian; Gaskell, Charlotte; Jackson, Aimee; Rhodes, Malcolm; Seale, Tania; Fox, Sonia; Hopkins, Lousie; Okosun, Jessica; Barrington, Sally F.; Ringshausen, Ingo; Ramsay, Alan G.; Calaminici, Maria; Linton, Kim; Bishton, Mark
errShare
errSave
Peripheral pharmacodynamic activity of epcoritamab as monotherapy and in combination with rituximab plus lenalidomide in patients with follicular lymphoma
err2024-03-22
err0
PREAI
errSi, Han; Zhang, Jimin; Wielgos-Bonvallet, Monica; Falchi, Lorenzo; Linton, Kim; Jurczak, Wojciech; Belada, David; Altintas, Isil; Sacchi, Mariana; Favaro, Elena; Rana, Ali; Hoehn, Daniela; Soong, David; Chiu, Christopher W.; Jure-Kunkel, Maria
errShare
errSave
errShare
errSave
Ibrutinib as fi rst-line therapy for mantle cell lymphoma: a multicenter, real-world UK study
err2024-03-01
err4
errOAAI
errTivey, Ann; Shotton, Rohan; Eyre, Toby A.; Lewis, David; Stanton, Louise; Allchin, Rebecca; Walter, Harriet; Miall, Fiona; Zhao, Rui; Santarsieri, Anna; Mcculloch, Rory; Bishton, Mark; Beech, Amy; Willimott, Victoria; Fowler, Nicole; Bedford, Claudia; Goddard, Jack; Protheroe, Sam; Everden, Angharad; Tucker, David; Wright, Josh; Dukka, Vasavi; Reeve, Miriam; Paneesha, Shankara; Prahladan, Mahesh; Hodson, Andrew; Qureshi, Iman; Koppana, Manasvi; Owen, Mary; Ediriwickrema, Kushani; Marr, Helen; Wilson, Jamie; Lambert, Jonathan; Wrench, David; Burney, Claire; Knott, Chloe; Talbot, Georgina; Gibb, Adam; Lord, Angela; Jackson, Barry; Stern, Simon; Sutton, Taylor; Webb, Amy; Wilson, Marketa; Thomas, Nicky; Norman, Jane; Davies, Elizabeth; Lowry, Lisa; Maddox, Jamie; Phillips, Neil; Crosbie, Nicola; Flont, Marcin; Nga, Emma; Virchis, Andres; Camacho, Raisa Guerrero; Swe, Wunna; Pillai, Arvind; Rees, Clare; Bailey, James; Jones, Steve; Smith, Susan; Sharpley, Faye; Hildyard, Catherine; Mohamedbhai, Sajir; Nicholson, Toby; Moule, Simon; Chaturvedi, Anshuman; Linton, Kim
errShare
errSave
Safety of bendamustine for the treatment of indolent non-Hodgkin lymphoma: a UK real-world experience
err2024-02-15
err3
errOAAI
errShotton, Rohan; Broadbent, Rachel; Alchawaf, Alia; Mohamed, Mohamed Bakri; Gibb, Adam; Martinez-Calle, Nicolas; Fox, Christopher P.; Bishton, Mark; Pender, Alexandra; Gleeson, Mary; Cunningham, David; Davies, Andrew; Yadollahi, Sina; Eyre, Toby A.; Collins, Graham; Djebbari, Faouzi; Kassam, Shireen; Garland, Paula; Watts, Emily; Osborne, Wendy; Townsend, William; Pocock, Rachael; Aheame, Matthew J.; Mial, Fiona; Wang, Xin; Linton, Kim M.
errShare
errSave
Pilot study of lung cancer screening for survivors of Hodgkin lymphoma
err2023-11-16
err2
errOAAI
errBroadbent, Rachel; Crosbie, Philip; Armitage, Christopher J.; Taylor, Ben; Tenant, Sean; Mercer, Joseph; Radford, John; Linton, Kim
errShare
errSave
Safety and efficacy of zanubrutinib in relapsed/refractory marginal zone lymphoma: final analysis of the MAGNOLIA study
err2023-11-15
err10
errOAAI
errOpat, Stephen; Tedeschi, Alessandra; Hu, Bei; Linton, Kim M.; Mckay, Pamela; Leitch, Sophie; Coleman, Morton; Zinzani, Pier Luigi; Jin, Jie; Sun, Mingyuan; Sobieraj-Teague, Magdalena; Browett, Peter; Ke, Xiaoyan; Thieblemont, Catherine; Ardeshna, Kirit; Bijou, Fontanet; Walker, Patricia; Hawkes, Eliza A.; Ho, Shir-Jing; Zhou, Keshu; Liang, Zhiyu; Xu, Jianfeng; Tankersley, Chris; Delarue, Richard; Co, Melannie; Trotman, Judith
errShare
errSave
Personalised therapy in follicular lymphoma - is the dial turning?
err2023-07-22
err2
errOAAI
errLinton, Kim M.; Specht, Lena; Pavlovsky, Astrid; Thompson, Carrie A.; Kimby, Eva; de Jong, Daphne; Nastoupil, Loretta J.; Cottereau, Anne-Segolene; Casulo, Carla; Sarkozy, Clementine; Okosun, Jessica
errShare
errSave
A retrospective study of MYC rearranged diffuse large B-cell lymphoma in the context of the new WHO and ICC classifications
err2023-04-18
err6
errOAAI
errEl-Sharkawi, Dima; Sud, Amit; Prodger, Catherine; Khwaja, Jahanzaib; Shotton, Rohan; Hanley, Brian; Peacock, Victoria; Peng, Ying Ying; Arasaretnam, Anita; Sharma, Sarkhara; Aldridge, Frances; Sharma, Bhupinder; Wotherspoon, Andrew; Cheung, Betty; De Lord, Corinne; Johnston, Rosalynd; Kassam, Shireen; Pettengel, Ruth; Linton, Kim; Greaves, Paul; Cook, Lucy; Naresh, Kikkeri N.; Cwynarski, Kate; Eyre, Toby A.; Chau, Ian; Cunningham, David; Iyengar, Sunil
errShare
errSave